111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
SHANGHAI, Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company...
Year: 2024
Censys Finds Over 14,000 Healthcare Devices and Records Exposed to the Internet
New research shows exposed medical record systems and images increase the risk of unauthorized access, data breaches and operational disruptions...
Humhealth’s Mobile App – Transforming Patient Care Through Technology
WIXOM, MI / ACCESSWIRE / October 10, 2024 / In today's fast-paced healthcare landscape, the Humhealth mobile app is a...
Aware Health Secures $3M in Seed Funding to Expand Value-Based Musculoskeletal Solutions
Funding led by Boomerang Ventures will fuel Aware Health's expansion of tele-rehab services, advanced diagnostic algorithms, and AI-driven platforms to...
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription...
Agape ATP Corporation – Synergising Innovation Across Business Pillars to Make the World a Better Place
ATPC Unveils Its Multifaceted Business Pillars to Drive Global Wellness and Sustainability KUALA LUMPUR, MALAYSIA / ACCESSWIRE / October 10,...
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
Oakville, Ontario--(Newsfile Corp. - October 10, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Safe Supply Streaming Provides Corporate Update and Strategic Vision
Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) ("Safe Supply Streaming" or the...
Steven Taylor, Arthritis Foundation CEO, Appointed to Advisory Council for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The announcement comes as the global arthritis community observes World Arthritis Day ATLANTA, GA / ACCESSWIRE / October 10, 2024...
SpendMend Announces Jeff Streelman as Vice President of Information Security
GRAND RAPIDS, MI / ACCESSWIRE / October 10, 2024 / SpendMend, the leading provider of cost-cycle management solutions for the...
New Poll: Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases
American voters are willing to pay more to ensure access and want Congress to step in if Medicare continues restricting...
AcutePet Urgent Care Expands to Mount Pleasant, South Carolina, Making Veterinary Urgent Care More Accessible for Pets and Their Owners
MOUNT PLEASANT, SC / ACCESSWIRE / October 10, 2024 / AcutePet Urgent Care is excited to announce the opening of...
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel GoldlustAccess the segment...
AI/ML Innovations Inc. Announces Impairment of Investment
VICTORIA, BC / ACCESSWIRE / October 10, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that, as...
International Myeloma Foundation Launches Clinical Trial Matching Engine in Partnership with SparkCures
SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org.STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE)...
Alpha Tau Treats First Patient with Recurrent Lung Cancer
JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics
DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
Company’s VP of Education and Global Training Named Chairman of ASRM Corporate Member CouncilATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) --...
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)
– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical...
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated...